10/12.5 Logo 5033 (Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg)
Pill imprint 10/12.5 Logo 5033 has been identified as Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg.
Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/lisinopril 12.5 mg / 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 10/12.5 Logo 5033 (Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg)
- 12.5 mg / 10 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
FD&C Blue No. 1
|NDC Code||Manufacturer / Repackager|
|23490-5820||Palmetto State Pharmaceuticals Inc (repackager)|
|43063-0118||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
Hydrochlorothiazide and lisinopril is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...